BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30306232)

  • 1. [Genetics of pheochromocytoma and the relevance in surgery].
    von Dobschütz E; Neumann HPH
    Chirurg; 2019 Jan; 90(1):15-22. PubMed ID: 30306232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
    Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
    Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial pheochromocytoma.
    Erlic Z; Neumann HP
    Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the genetics of familial chromaffin cell tumors.
    Koch CA; Vortmeyer AO; Zhuang Z; Brouwers FM; Pacak K
    Ann N Y Acad Sci; 2002 Sep; 970():11-28. PubMed ID: 12381538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
    Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of hereditary pheochromocytoma.
    Yip L; Lee JE; Shapiro SE; Waguespack SG; Sherman SI; Hoff AO; Gagel RF; Arens JF; Evans DB
    J Am Coll Surg; 2004 Apr; 198(4):525-34; discussion 534-5. PubMed ID: 15051000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial pheochromocytomas and paragangliomas: stories from the sign-out room.
    Perren A; Komminoth P
    Endocr Pathol; 2006; 17(4):337-44. PubMed ID: 17525482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetics of pheochromocytoma].
    Bausch B; Malinoc A; Maruschke L; Offergeld C; Gläsker S; Rischke HC; Brauckhoff M; Boedeker CC; Neumann HP
    Chirurg; 2012 Jun; 83(6):511-8. PubMed ID: 22481546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytoma: the expanding genetic differential diagnosis.
    Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
    J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
    Boedeker CC; Erlic Z; Richard S; Kontny U; Gimenez-Roqueplo AP; Cascon A; Robledo M; de Campos JM; van Nederveen FH; de Krijger RR; Burnichon N; Gaal J; Walter MA; Reschke K; Wiech T; Weber J; Rückauer K; Plouin PF; Darrouzet V; Giraud S; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1938-44. PubMed ID: 19336503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The approach to the patient with paraganglioma.
    Neumann HP; Eng C
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2677-83. PubMed ID: 19657044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
    Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
    Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
    Fishbein L
    Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
    Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
    JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.
    Castinetti F; Taieb D; Henry JF; Walz M; Guerin C; Brue T; Conte-Devolx B; Neumann HP; Sebag F
    Eur J Endocrinol; 2016 Jan; 174(1):R9-18. PubMed ID: 26297495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How many pathways to pheochromocytoma?
    Neumann HP; Hoegerle S; Manz T; Brenner K; Iliopoulos O
    Semin Nephrol; 2002 Mar; 22(2):89-99. PubMed ID: 11891502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.